Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
17/03/2009	13h00	Business Wire	Allos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the Eu...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/03/2009	23h29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/03/2009	22h03	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/03/2009	22h00	Business Wire	Allos Therapeutics Reports 2008 Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
26/02/2009	22h00	Business Wire	Allos Therapeutics to Report 2008 Results on March 3, 2009	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/02/2009	22h24	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/02/2009	22h49	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/12/2008	22h00	Business Wire	Allos Therapeutics to Present at the RBC Capital Markets 2008 Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/12/2008	17h03	Business Wire	Allos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/12/2008	18h30	Business Wire	Two Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/12/2008	14h00	Business Wire	Allos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/12/2008	22h00	Business Wire	U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/11/2008	22h00	Business Wire	U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/11/2008	23h09	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/11/2008	15h17	Business Wire	Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	23h09	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	22h00	Business Wire	Allos Therapeutics Reports 2008 Third Quarter Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/11/2008	14h00	Business Wire	Allos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/10/2008	21h00	Business Wire	Four Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/10/2008	13h00	Business Wire	Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/10/2008	14h00	Business Wire	Allos Therapeutics to Present at the JMP Healthcare Focus Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/09/2008	15h05	Edgar (US Regulatory)	Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/09/2008	23h06	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/09/2008	14h00	Business Wire	Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/08/2008	22h00	Business Wire	Allos Therapeutics to Present at the NewsMakers in the Biotech Industry Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/08/2008	22h17	Edgar (US Regulatory)	Allos Therapeutics Inc - Amended Annual Report (10-K/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	23h30	Edgar (US Regulatory)	Allos Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	22h03	Edgar (US Regulatory)	Allos Therapeutics Inc - Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	22h00	Business Wire	Allos Therapeutics Reports 2008 Second Quarter Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/07/2008	14h00	Business Wire	Allos Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)